Navigation Links
BioMS Medical to present at 2008 BIO International Convention
Date:6/12/2008

Toronto Stock Exchange Symbol: MS

EDMONTON, June 12 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Kevin Giese, President and CEO, will present at the Business Forum at the 2008 BIO International Convention in San Diego, California.

WHEN: Friday June 20th at 10:15 am (PDT)

WHERE: San Diego Convention Center, San Diego

About the 2008 BIO International Convention

The 2008 BIO International Convention, hosted by the Biotechnology Industry Organization, will feature keynotes from industry and global leaders, more than 175 breakout sessions, business partnering meetings, and numerous networking events. The convention also includes more than 200,000 square feet of exhibitions showcasing the latest advancements in biotechnology alongside an array of potential partners, service providers, and state and international delegations. For more information visit http://www.bio2008.org/.

About BioMS Medical Corp.

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298 (dirucotide), is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. In December 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to MBP8298 (dirucotide) in exchange for an $87 million upfront payment, milestone payments and escalating royalties on sales. For further information please visit our website at

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
2. BioMS Medical announces first quarter 2008 results
3. BioMs Medical to present at TIDES(R) Conference
4. BioMS Medical to present at Rodman and Renshaw Global Healthcare Conference
5. BioMS Medical Provides Update On Pipeline Products
6. BioMS Medical announces conference call and web cast for Annual General Meeting
7. BioMS Medical to Participate in Speciality Panel Session at BioFinance 2008
8. BioMS Medical to present at EQUITIES Conference
9. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
10. BioMS Medical to present at BioCentury Conference
11. BioMS Medical Announces 2007 Year End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Selexis SA, a serial innovation company ... (RCBs) used for drug discovery to commercial manufacturing, announced ... Next-Generation Sequencing (NGS) data packages. The NGS ... by ensuring the integrity of the gene, validation of ...
(Date:1/22/2015)... , Jan. 22. 2015  Varian Medical Systems (NYSE: ... been honored for its commitment to sustainability with inclusion on ... is the highest ranked healthcare equipment company among the Corporate ... the World Economic Forum at Davos, Switzerland ...
(Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
(Date:12/24/2014)... “Preparative & Process Chromatography Market by Instrument ... Buffers, Valves, Guages, Seals), Accessories, Services, End User ... 2019” provides a detailed overview of the major ... strategies impacting the preparative and process chromatography market ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4
... Pharmaceuticals, Inc. (NYSE: WPI ) today announced ... from the United States Food and Drug Administration on ... tablets, the generic equivalent to Roche,s BONIVA® tablets. Watson ... quarter. BONIVA® 150mg tablets had total U.S. sales of ...
... 2012 Creative Bioscience, a leading maker of dietary supplements ... African Mango Lean ™, African Mango 1200 ™, ... and its new Raspberry Ketone 1234 ™ weight loss ... Markets locations across the West and Southwest. ...
...  The San Diego entrepreneur group Bootstrappers Breakfast ( www.bootstrappersbreakfast.com ... a.m. on the last Friday of every month. The ... breakfast" is Friday, March 30 at 7:30 a.m. at ... Attendees, all with an entrepreneurial streak, discuss innovative ways to ...
Cached Biology Technology:Watson's Generic BONIVA® 150mg Receives FDA Approval 2Creative Bioscience All-Natural Dietary Supplements Now Available at Sprouts Farmers Market 2Creative Bioscience All-Natural Dietary Supplements Now Available at Sprouts Farmers Market 3Entrepreneurs to Eat Problems for Breakfast in San Diego 2
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ... their offering. One major trend emerging ... advances in technology, it is important to upgrade biometric ...
(Date:12/11/2014)... 2014  Data Sciences International (DSI), the global leader ... series of digital telemetry implants to meet the ... part of the PhysioTel™ Digital platform, was designed ... data when incorporating functional endpoints into repeat-dose toxicology ...
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical Center today ... School of Medicine. Funding for this $50 million capital project ... publicly launched next summer. The medical education ... Reynolds Tobacco Company complex, adjacent to 525@vine in Wake Forest ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... 2, 2012 Biochemist and geneticist Alexander Varshavsky (California Institute ... lived in the USA since 1977, has been awarded the ... Molecular Biology (GBM). That medal is considered to be the ... By means of genetic research carried out with yeast and ...
... among his most vibrant and celebrated works, Vincent van Gogh,s ... basis has, until now, been a mystery. In a study ... of Georgia scientists reveal the mutation behind the distinctive, thick ... more than 100 years ago. The most common sunflower ...
... parasite, less resistance can sometimes be better than more, a ... known as Daphnia dentifera endures periodic epidemics of ... percent of the Daphnia population. During these epidemics, the ... A new study led by Georgia Institute of Technology ...
Cached Biology News:Otto Warburg Medal for Alexander Varshavsky 2Otto Warburg Medal for Alexander Varshavsky 3Genetic mutation depicted in van Gogh's sunflower paintings revealed by scientists 2Weakness can be an advantage in surviving deadly parasites, a new study shows 2Weakness can be an advantage in surviving deadly parasites, a new study shows 3
... Art GLP facility with capabilities from ... fermentation. Coordinated process development from ... operation capable of simultaneous production runs ... Hosts include: Bacteria, Yeast, Fungi, ...
Request Info...
Immunogen: VDAC3 Protein Storage: -20 C, Avoid Freeze/Thaw Cycles...
... 75 x 25 ... recommended for immunohistochemistry of paraffin-embedded sections, ... one end, markings will ... procedures, precleaned, ...
Biology Products: